KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Non-Current Debt: 2009-2014

Historic Non-Current Debt for Novavax (NVAX) over the last 6 years, with Dec 2014 value amounting to $395,000.

  • Novavax's Non-Current Debt was N/A to $45,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $45,000, marking a year-over-year change of. This contributed to the annual value of $395,000 for FY2014, which is 60.66% down from last year.
  • Per Novavax's latest filing, its Non-Current Debt stood at $395,000 for FY2014, which was down 60.66% from $1.0 million recorded in FY2013.
  • Novavax's Non-Current Debt's 5-year high stood at $1.0 million during FY2013, with a 5-year trough of $300,000 in FY2011.
  • Its 3-year average for Non-Current Debt is $717,333, with a median of $753,000 in 2012.
  • Its Non-Current Debt has fluctuated over the past 5 years, first surged by 151.00% in 2012, then slumped by 60.66% in 2014.
  • Novavax's Non-Current Debt (Yearly) stood at $320,000 in 2010, then dropped by 6.25% to $300,000 in 2011, then soared by 151.00% to $753,000 in 2012, then skyrocketed by 33.33% to $1.0 million in 2013, then crashed by 60.66% to $395,000 in 2014.